dasatinib price

 


Dasatinib, marketed as Dasacine, is a chemotherapy medicine. It’s prescribed for the treatment of patients with certain blood cancers. The medicine is approved to treat acute lymphoblastic leukemia and chronic myeloid leukemia. It has a strength of 50mg per tablet. Dasacine is mostly prescribed in conditions where imatinib stops working. It may show side effects like ear pain, body ache, black stools, and fever. If you are looking for the dasatinib price, please visit Magicine Pharma. Save up to 24% on your first order.

Comments

Post a Comment

Popular posts from this blog

TREATMENT OF OBESITY

  A suitably planned course of dietetic treatment, in conjunction with suitable exercise and other measures for promoting elimination is the only scientific way of dealing with obesity. The chief consideration in this treatment should be the balanced selection of foods which provide the maximum essential nutrients with the least number of calories. There should be a gradual weight reduction . The aim is to maintain ideal body weight and to correct faulty eating habits. Let us understand the tips individually. A. The total energy intake for the day should be adjusted to meet the individual weight reduction requirement. SAAOL 's recommended dietary allowance for a person performing a minimum amount of (sedentary) work is 1600 calorie/day. B. A total vegetarian diet should be followed as consumption of meat, fish, chicken, poultry, mutton etc will increase the cholesterol and triglyceride levels and ultimately the amount of fat in the body. C. As carbohydrates (all cereals,
Read more

SUCCESS OF ANGIOPLASTY - THE HIDDEN FACTS

Image
The medical world claims that the success rate for PTCA exceeds 95% for dilating a target lesion (blockage) so that its residual stenosis is <50% (<30% when a stent has been used). Is it actually a success? After paying your hard earned money, you actually get a reblockage of 30%-50% immediately after the angioplasty ! And the time required to reach back to more than 70% is easy to guess. No wonder you get so many cases of reblockage occurring within no time. In approximately 20% of patients, evidence of recurrent ischaemia (reblockage i.e. Blockage more than 70%), develops within 6 months, due to restenosis of dilated segment. But the hospitals try to convert this failure of PTCA into a success story by hiding the actual facts from the patients. How can this procedure be successful when 20 people out of 100 get reblocks just within six months? The actual figure will be very high, these are the figures which the official statistics claim! About half of the failures of PTCA res
Read more